-
Policy Matters
Progress in the Youth E-cigarette EpidemicNew data reveal a decrease in youth e-cigarette use but underscore the need for continued policy and advocacy efforts.
by Brad Davidson, PhD
-
Get Involved
Treasure TroveThe Pediatric Oncology Treasure Chest Foundation provides toys and gifts to young cancer patients.
by Thomas Celona
-
Let Me Tell You a Story About the Power of Medical ResearchTen-year-old Michael Methner told his story about being diagnosed with optic nerve glioma at the AACR’s Rally for Medical Research.
by Cancer Research Catalyst
-
Forward Look
Medicare Rule Expands Access to Navigation ServicesExperts hope Medicare reimbursement for patient navigation will allow more treatment sites to offer this assistance.
by Carolyn Bernhardt
-
Forward Look
The Cost of Dental Side EffectsHead and neck cancer survivors often face significant costs for treatments not covered by health insurance.
by Kris Conner
-
Policy Matters
The Future of Perioperative Clinical Trial DesignsA recent FDA-AACR workshop explored best practices for trial design, analysis and interpretation of clinical studies with multiple phases of treatment.
by Elizabeth M. Jaffee, MD
-
Patients as Research PartnersNew platforms allow patients to share their clinical data and tumor tissue no matter where they live, offering everyone a chance to participate in research.
by Erin O'Donnell
-
Get Involved
Happy FeetThe HallieStrong Foundation sends people receiving cancer treatment socks designed to put smiles on their faces.
by Thomas Celona
-
Advocacy After LossFollowing her son’s death from peripheral T-cell lymphoma, Sandy McHugh keeps his memory alive through Jake’s Dragon Foundation.
by Thomas Celona
-
Get Involved
Ground SupportHouston-based nonprofit offers free rides to and from medical appointments for people with cancer.
by Thomas Celona
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
